More on DRMA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dermata Therapeutics, Inc (NQ:DRMA)
Delayed: 0.86 -0.05 (5.49%)
Prev. Close $0.91  
Open$0.91 
52 Wk High$ 
52 Wk Low$ 
Day High$0.95 
Day Low$0.81 
P/E N/A  
EPS$ 
Volume2,514,697 

Friends, Peers and Foes (?): DRMAW (more...)

Oct 15, 2026 08:06 AM Dermata reports cosmetic study results for Tome skin treatment
Oct 15, 2026 08:06 AM Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Oct 9, 2026 04:06 PM Form S-3 Dermata Therapeutics,
Aug 25, 2026 08:31 AM Dermata launches first Tome skincare product for consumers
Aug 25, 2026 08:31 AM Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Aug 21, 2026 08:30 AM Dermata opens preorders for Tome skincare product at $178
Aug 21, 2026 08:30 AM Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Aug 18, 2026 05:25 PM Form 4 Dermata Therapeutics, For: Aug 16 Filed by: PROEHL GERALD T
Aug 18, 2026 05:22 PM Form 4 Dermata Therapeutics, For: Aug 16 Filed by: Van Hoose Kyri K.
Aug 17, 2026 04:23 PM Form 25-NSE Dermata Therapeutics, Filed by: Nasdaq Stock Market LLC
View All Articles

Entities mentioned with DRMA

View All Entities